Literature DB >> 8279775

A randomized trial on tamoxifen continuation during second-line hormone therapy in breast cancer.

P Pronzato1, G Bertelli, M Rosso.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8279775     DOI: 10.1111/j.1749-6632.1993.tb17226.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  1 in total

Review 1.  Is there a growing role for endocrine therapy in the treatment of breast cancer?

Authors:  P E Lønning
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.